Scarica l'app Stockscreener
7.87
7.51%
0.55
Dopo l'orario di chiusura:
7.90
0.03
+0.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.32
Aprire:
$7.38
Volume 24 ore:
295.02K
Relative Volume:
0.96
Capitalizzazione di mercato:
$146.70M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-9.8375
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
+1.03%
1M Prestazione:
-28.58%
6M Prestazione:
-57.71%
1 anno Prestazione:
+49.05%
Intervallo 1D:
$7.20
$7.96
Intervallo di 1 settimana:
$6.84
$8.06
Portata 52W:
$3.9914
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
7.87 | 136.45M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-07-25 | Ripresa | B. Riley Securities | Buy |
| 2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2023-02-02 | Ripresa | B. Riley Securities | Buy |
| 2022-11-01 | Iniziato | Stifel | Buy |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2021-10-18 | Ripresa | B. Riley Securities | Buy |
| 2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Corp expected to post earnings of 23 cents a shareEarnings Preview - TradingView
OPRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Portfolio Update: Can OptimizeRx Corporation weather a recessionJuly 2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
OptimizeRx (OPRX) Projected to Post Quarterly Earnings on Thursday - Defense World
Can OptimizeRx Corporation sustain earnings growthQuarterly Trade Review & Breakout Confirmation Alerts - mfd.ru
Is OptimizeRx Corporation stock trending bullishPortfolio Return Summary & Step-by-Step Trade Execution Guides - mfd.ru
CenterBook Partners LP Invests $6.33 Million in OptimizeRx Corp. $OPRX - MarketBeat
OptimizeRx (OPRX): Small-Cap AI Health Stock Quietly Repricing Higher - AD HOC NEWS
US Market Recap: Can OptimizeRx Corporation maintain sales growthEarnings Beat & Long-Term Growth Plans - baoquankhu1.vn
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $21.00 - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Portfolio Update: Can OptimizeRx Corporation sustain earnings growth2025 Price Targets & Daily Volume Surge Trade Alerts - baoquankhu1.vn
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET - The Manila Times
OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial - GlobeNewswire
Strength Seen in OptimizeRx (OPRX): Can Its 7.5% Jump Turn into More Strength? - Yahoo Finance
OptimizeRx (NASDAQ:OPRX) Stock Price Down 6.1%Here's What Happened - MarketBeat
Day Trade: Can OptimizeRx Corporation ride the EV waveJuly 2025 Review & Expert Verified Stock Movement Alerts - baoquankhu1.vn
How Evolving Valuation Assumptions Are Rewriting The Story For OptimizeRx (OPRX) - Yahoo Finance
Market Outlook: Will OptimizeRx Corporation benefit from sector rotation2025 Risk Factors & AI Powered Trade Plan Recommendations - baoquankhu1.vn
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Is OptimizeRx Corporation stock attractive after correctionSell Signal & Daily Profit Maximizing Trade Tips - Улправда
OptimizeRx (OPRX): Clinical Network Growth Drives 37% Reach Boost Amid Analyst Upgrades - Finviz
9 Best Performing Micro Cap Stocks in 2025 - Insider Monkey
OptimizeRx and Experian collaborate to improve privacy-safe identity resolution in healthcare marketing - MarketScreener
OptimizeRx Corp. and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - marketscreener.com
OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing - The Manila Times
New data tie-up aims to make consumer health ads more precise and private - Stock Titan
Best Growth Stocks to Buy for July 22nd - MSN
Head to Head Comparison: Manhattan Associates (NASDAQ:MANH) and OptimizeRx (NASDAQ:OPRX) - Defense World
OptimizeRx (NASDAQ:OPRX) Insider Sells $18,751.88 in Stock - MarketBeat
OptimizeRx CFO sells $18,751 in shares By Investing.com - Investing.com Nigeria
OptimizeRx CFO sells $18,751 in shares - Investing.com
OptimizeRx Corp Executive Sells Shares - TradingView — Track All Markets
How OptimizeRx Corporation stock responds to policy changesMarket Rally & Stepwise Trade Signal Implementation - Улправда
Is OptimizeRx Corporation stock oversold or undervaluedRecession Risk & AI Forecast for Swing Trade Picks - Улправда
Is OptimizeRx Corporation stock a good choice for value investors2025 EndofYear Setup & High Accuracy Investment Signals - DonanımHaber
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
OptimizeRx (NASDAQ:OPRX) Cut to “Hold” at Zacks Research - Defense World
OptimizeRx (NASDAQ:OPRX) Cut to "Hold" at Zacks Research - MarketBeat
OPRX FinancialsIncome Statement - Quiver Quantitative
OptimizeRx Corp. Expands Point-of-Care Network with Four New Partner Agreements - Quiver Quantitative
OptimizeRx Continues Expansion of the Company’s Point-Of-Care Network - The Manila Times
New partnerships plug drug makers into more doctors’ EHR workflows - Stock Titan
Officer D'Silva Surrenders 868 Of OptimizeRx Corp [OPRX] - TradingView — Track All Markets
OptimizeRx Corp (OPRX) insider has 868 shares withheld for taxes - Stock Titan
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to “Strong-Buy” - Defense World
Wall Street Zen Upgrades OptimizeRx (NASDAQ:OPRX) to "Strong-Buy" - MarketBeat
Looking at the Narrative for OptimizeRx After Guidance Boost and Recurring Revenue Shift - Yahoo Finance
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Optimizerx Corp Azioni (OPRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
0.25%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):